Scarica l'app Stockscreener
563.16
1.54%
-9.1639
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$572.32
Aprire:
$570
Volume 24 ore:
510.22K
Relative Volume:
0.22
Capitalizzazione di mercato:
$209.21B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
30.96
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
+5.83%
1M Prestazione:
+14.49%
6M Prestazione:
-9.98%
1 anno Prestazione:
+18.62%
Intervallo 1D:
$559.44
$574.00
Intervallo di 1 settimana:
$495.04
$587.49
Portata 52W:
$435.27
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
562.97 | 212.69B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
192.67 | 135.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
542.11 | 42.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
138.76 | 39.47B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
265.47 | 37.91B | 2.50B | -226.32M | 71.51M | -1.6412 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc. (TMO) Leads with RSI of 73 Amid Ea - GuruFocus
Thermo Fisher Raised Full-Year Guidance After a Standout Q2 Earnings Call - TIKR.com
RBC Raises Price Target on Thermo Fisher Scientific to $580 From $490, Keeps Sector Perform Rating - marketscreener.com
Barclays Adjusts Thermo Fisher Scientific Price Target to $650 From $625, Maintains Overweight Rating - marketscreener.com
Thermo Fisher raises 2026 outlook after 10% growth in Q2 - Yahoo Finance
Bernstein Adjusts PT on Thermo Fisher Scientific to $575 From $520, Maintains Market Perform Rating - marketscreener.com
Thermo Fisher (TMO) Lands ImmuPharma Kapiglucagon Diabetes Manufacturing Role - Yahoo Finance
Thermo Fisher stock holds steady ahead of earnings - Ad-hoc-news.de
Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades - Yahoo! Finance Canada
Thermo Fisher Scientific Q2 Earnings Call Highlights - Yahoo Finance
TMO Q2 FY2026 earnings call - finance.biggo.com
Is It Too Late to Buy Thermo Fisher Scientific Inc (TMO) After 8 - GuruFocus
Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $606.79, Implies 15% Upside - TradingView
Thermo Fisher Scientific Inc.'s stock price skyrockets to $572.32, marking an impressive 8.71% surge - Smartkarma
Thermo Fisher Stock Jumps on Second Quarter Results - WFMZ.com
Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call Highlig - GuruFocus
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific (TMO) Reports Strong Q2 2026 Earnings a - GuruFocus
Thermo Fisher Points to Improving End-Market ActivityThermo Fisher Scientific (NYSE:TMO) - Benzinga
Leerink Partners Adjusts Price Target on Thermo Fisher to $620 From $600, Maintains Outperform Rating - marketscreener.com
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $630 From $585, Maintains Buy Rating - marketscreener.com
Thermo Fisher TMO Stock Draws Bullish Calls Ahead Of Q2 - timothysykes.com
Thermo Fisher Scientific Reports Second Quarter 2026 Results - BioSpace
Thermo Fisher Scientific (NYSE:TMO) Gains Focus In A Selective Market - Kalkine Media
Why Is Thermo Fisher (TMO) Stock Rocketing Higher Today - Yahoo Finance
Thermo Fisher Q2 revenue rises 10% to $11.99 billion - grafa.com
Thermo Fisher Stock Draws Bullish Targets Ahead Of Q2 - StocksToTrade
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 9.89% on Jul 23: A Full Analysis - TradingKey
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $615 From $570 - marketscreener.com
Thermo Fisher Stock Climbs As Analysts Hike Targets Ahead Q2 - timothysykes.com
TMO Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-Market - The Globe and Mail
Thermo Fisher Rises as Instrument Demand Recovery Lifts Outlook - Bloomberg.com
Thermo Fisher (NYSE:TMO) shares gain as instrument margins exceed sales growth - TechStock²
Thermo Fisher raises annual profit forecast as customer demand improves - Reuters
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday - Benzinga
Thermo Fisher Scientific Stock Climbs As Analysts Ramp Up Bullish Calls - StocksToTrade
Why is Thermo Fisher Scientific stock surging today? - Investing.com
Earnings call transcript: Thermo Fisher tops Q2 2026 estimates and lifts outlook - Investing.com
Here's What Key Metrics Tell Us About Thermo Fisher (TMO) Q2 Earnings - Yahoo Finance
Thermo Fisher stock rebounds after Q2 beat (update) (TMO:NYSE) - Seeking Alpha
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 6, 2025. - marketscreener.com
Thermo Fisher beats second-quarter expectations as customer demand strengthens (NYSE:TMO) - Yahoo Finance
Thermo Fisher Scientific (TMO) Q2 2026 earnings summary - Quartr
Thermo Fisher Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026 - marketscreener.com
Thermo Fisher Scientific (TMO) Reports Strong Q2 Earnings with R - GuruFocus
Thermo Fisher Scientific (TMO) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Is Thermo Fisher Scientific Inc. (TMO) Undervalued After Q2 Earn - GuruFocus
Thermo Fisher Q2 EPS beats estimates on 10% sales growth - scanx.trade
Why is Thermo Fisher Scientific stock surging today? By Investing.com - Investing.com Canada
Pyridine & Pyridine Derivatives Market Size to Reach USD 1,255.74 Million by 2035 on Rising Agrochemical and Pharma Demand | SNS Insider - GlobeNewswire Inc.
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):